Navigation Links
SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents
Date:7/21/2010

About SemBioSys

Calgary, Alberta-based SemBioSys is focused on leveraging its unique proprietary platform to manufacture high-value proteins and oils. SemBioSys' seed-based protein production system can provide for its partners product enablement, exceptionally low cost and unprecedented scalability. SemBioSys is applying the platform with high selectivity to products with tremendous clinical promise and value potential. The Company's current pharmaceutical development programs include insulin (SBS-1000, regulated as a biosimilar in Europe) and Apo AI(Milano), a next-generation cardiovascular therapy. SemBioSys is listed on the Toronto Stock Exchange under the ticker SBS. More information is available at www.sembiosys.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, changing market conditions and market size, the acceptance of an IND by the FDA in respect of clinical studies, the submission of a CTA to the appropriate European auth
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SemBioSys updates progress on Apo AI(Milano)
2. SemBioSys securityholder vote to be held December 18, 2009 with a record date of November 16, 2009
3. SemBioSys announces third quarter 2009 financial and operational results
4. SemBioSys provides an update on Botaneco
5. Data for SemBioSys insulin to be presented at the American Diabetes Associations 69th Scientific Sessions
6. SemBioSys plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models
7. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
8. SemBioSys provides update on insulin program
9. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
10. SemBioSys announces senior management changes
11. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal Products ... selected by Buffalo BioBlower Technologies LLC ("B3") as the ... Phase 2 award from the Army Corps of Engineers.  ... that kills all biological contaminants and destroys VOCs and ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... conjugates for cancer, today announced the appointment of Thomas C ... has over 20 years, development experience gained in the biotechnology ... "I am delighted to welcome Tom at this ...
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... 11 Serica Technologies, Inc., a,growth-stage medical ... recently completed the first manufacturing run of ... Serica,s new headquarters in,Medford, MA, includes 22,000 ... as well as manufacturing and administrative,space. The ...
... on the nation,s obesity crisis by addressing ... associated with hunger and excess weight., SAN DIEGO, ... company, announced the launch of GenoTrim, a DNA-based,nutritional solution ... both standard weight reduction strategies and numerous,"gimmicks" have proven ...
... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced ... Officer, will provide a corporate,presentation at the UBS ... 24, 2007 at 4:00 p.m. Eastern time. ... accessed by visiting the,Investors section of the Jazz ...
Cached Biology Technology:Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing 2Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing 3Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 2Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 3
(Date:4/24/2014)... of America (ESA) is very pleased to announce that ... Insect Science from the University of Wisconsin. , ... is an international, open-access, peer-reviewed journal that publishes papers ... other arthropods -- from the molecular to the ecological ... It is freely available to individuals and institutions, and ...
(Date:4/24/2014)... State University and the University of North Carolina at ... could help identify arterial plaque that is at high ... stroke. , At issue is the plaque that builds ... plaque are deemed "vulnerable," meaning that they are more ... heart attack or stroke. , "Existing state-of-the-art technologies are ...
(Date:4/24/2014)... clear liquid can bend light, acting as a lens. ... a new process to create inexpensive high quality lenses ... , Because they,re so inexpensive, the lenses can be ... detect diseases in the field, scientific research in the ... classrooms. , "What I,m really excited about is ...
Breaking Biology News(10 mins):ESA to publish the Journal of Insect Science 2New ultrasound device may add in detecting risk for heart attack, stroke 2Bake your own droplet lens 2Bake your own droplet lens 3
... reefs are on the decline, with over-harvesting and pollution ... the last two centuries. With a growing awareness ... coasts from storm damage, and providing habitat for other ... in order to better understand the organisms and offer ...
... the researchers surrounding Prof. Dr. Martina Havenith (Physical Chemistry II ... Communication in the prestigious American chemistry journal, the Journal ... reviewers evaluated the work as one of the top 5% ... Temperatures of minus 1.8 C should really be ...
... CAMBRIDGE, Mass. -- Scientists at Harvard University have found that ... circuits as those used in more mundane choices related to ... other animals, put together two critical pieces of information: How ... are the odds that they will happen, depending on one,s ...
Cached Biology News:Cement, the glue that holds oyster families together 2Cement, the glue that holds oyster families together 3Why fish don't freeze in the Arctic Ocean 2Major moral decisions use general-purpose brain circuits to manage uncertainty 2Major moral decisions use general-purpose brain circuits to manage uncertainty 3